Paul Tudor Jones Enanta Pharmaceuticals Inc Put Options Transaction History
Tudor Investment Corp Et Al
- $15.5 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ENTA
# of Institutions
108Shares Held
21.7MCall Options Held
9.4KPut Options Held
3.3K-
Farallon Capital Management LLC San Francisco, CA2.1MShares$25.7 Million0.17% of portfolio
-
Morgan Stanley New York, NY2.05MShares$25.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.93MShares$23.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.84MShares$22.5 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY1.24MShares$15.1 Million0.29% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $254M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...